Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2

The COVID-19 pandemic is ongoing, and the need for safe and effective vaccines to prevent infection and to control spread of the virus remains urgent. Here, we report the development of a SARS-CoV-2 subunit vaccine candidate (Betuvax-CoV-2) based on RBD and SD1 domains of the spike (S) protein fused...

Descripción completa

Detalles Bibliográficos
Autores principales: Krasilnikov, Igor V., Kudriavtsev, Aleksandr V., Vakhrusheva, Anna V., Frolova, Maria E., Ivanov, Aleksandr V., Stukova, Marina A., Romanovskaya-Romanko, Ekaterina A., Vasilyev, Kirill A., Mushenkova, Nataliya V., Isaev, Artur A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782008/
https://www.ncbi.nlm.nih.gov/pubmed/35062730
http://dx.doi.org/10.3390/vaccines10010069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782008/
https://www.ncbi.nlm.nih.gov/pubmed/35062730
http://dx.doi.org/10.3390/vaccines10010069

Ejemplares similares